The Immuno-Oncology Drugs Global Market Report 2021-31 by The Business Research Company describes and explains the global immuno-oncology drugs market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The Immuno-Oncology Drugs Global Market Report 2022 covers immuno-oncology drugs market drivers, immuno-oncology drugs market trends, immuno-oncology drugs market segments, immuno-oncology drugs market growth rate, immuno-oncology drugs market major players, and immuno-oncology drugs market size.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
The immuno-oncology drugs market report provides in-depth analysis of the impact of COVID-19 on the global immuno-oncology drugs industry along with revised market numbers due to the effects of the coronavirus and the expected immuno-oncology drugs market growth numbers for 2022-2031.
The global immuno-oncology drugs market size is expected to grow from $60.32 billion in 2021 to $70.59 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The immuno-oncology market share is expected to reach $120.37 billion in 2026 at a CAGR of 14.3%.
Request Report Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp
Immuno-Oncology Drugs Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
TBRC’s report covers the immuno-oncology drugs market segments-
1) By Type: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Others
2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Others
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes
List Of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Immuno-Oncology Drugs Market, Segmentation By End-user, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
….
Figure 46: Amgen, Inc. Financial Performance
Figure 47: AstraZeneca Plc Financial Performance
Figure 48: Bristol-Myers Squibb Financial Performance
Figure 49: Celgene Corporation Financial Performance
Figure 50: Eli Lilly and Company Financial Performance
Here are some of the similar reports:
Cancer Diagnostics Global Market
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Clinical Oncology Next Generation Sequencing Global Market
https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Find us on
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
Blog: http://blog.tbrc.info/
